We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Social Capital Suvretta Holdings Corporation IV | NASDAQ:DNAD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.35 | 10.35 | 10.38 | 0 | 00:00:00 |
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Cayman Islands
|
98-1586546
|
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
Title of each class
|
Trading
Symbol
|
Name of each exchange
on which registered
|
||
Class A ordinary shares, $0.0001 par value per share
|
DNAD
|
Nasdaq Capital Market
|
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer
|
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
|
|
Page
|
|
||
|
||
|
1
|
|
|
2
|
|
|
3
|
|
|
4
|
|
|
5
|
|
|
14
|
|
|
16
|
|
|
16
|
|
|
||
|
17
|
|
|
17
|
|
|
17
|
|
|
17
|
|
|
17
|
|
|
17
|
|
|
18
|
|
|
19
|
ASSETS
|
||||
Current assets
|
||||
Cash
|
$ | 542,579 | ||
Prepaid expenses
|
897,311 | |||
|
|
|||
Total Current Assets
|
1,439,890 | |||
Marketable Securities held in Trust Account
|
250,003,042 | |||
|
|
|||
TOTAL ASSETS
|
$
|
251,442,932
|
|
|
|
|
|||
LIABILITIES, TEMPORARY EQUITY AND PERMANENT DEFICIT
|
||||
Current liabilities
|
||||
Accrued expenses
|
$ | 16,316 | ||
Advance from related parties
|
38,106 | |||
|
|
|||
Total Current Liabilities
|
|
54,422
|
|
|
Deferred underwriting fee payable
|
7,700,000 | |||
|
|
|||
TOTAL LIABILITIES
|
|
7,754,422
|
|
|
Commitments and Contingencies (Note 7)
|
||||
Temporary Equity
|
||||
Class A ordinary share
s
subject to possible redemption with 25,000,000 shares at redemption value
|
250,003,042 | |||
Permanent Deficit
|
||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
|
— | |||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 640,000 shares issued and outstanding (excluding 25,000,000 shares subject to possible redemption)
|
64 | |||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,250,000 shares issued and outstanding
|
625 | |||
Additional
paid-in
capital
|
— | |||
Accumulated deficit
|
(6,315,221 | ) | ||
|
|
|||
Total Permanent Deficit
|
|
(6,314,532
|
)
|
|
TOTAL LIABILITIES, TEMPORARY EQUITY AND PERMANENT DEFICIT
|
$
|
251,442,932
|
|
|
|
|
|
|
|
Three
Months Ended September 30, 2021 |
For the
Period from
February 25,
2021 (Inception) Through September 30, 2021 |
|||||||
Operating and formation costs
|
$ | 253,940 | $ | 259,265 | ||||
|
|
|
|
|||||
Loss from operations
|
|
(253,940
|
)
|
|
(259,265
|
)
|
||
Other income:
|
||||||||
Interest earned on marketable securities held in Trust Account
|
3,042 | 3,042 | ||||||
|
|
|
|
|||||
Total other income
|
3,042 | 3,042 | ||||||
Net loss
|
$
|
(250,898
|
)
|
$
|
(256,223
|
)
|
||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to redemption
|
25,358,242 | 10,884,906 | ||||||
|
|
|
|
|||||
Basic and diluted net loss per share, Class A ordinary shares subject to redemption
|
(0.01 | ) | (0.02 | ) | ||||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding,
Non-redeemable
Class A and B ordinary shares
|
6,241,758 | 5,818,396 | ||||||
|
|
|
|
|||||
Basic and diluted net loss per share,
Non-redeemable
Class A and B ordinary shares
|
$
|
(0.01
|
)
|
$
|
(0.02
|
)
|
||
|
|
|
|
Temporary Equity
|
Class A
Ordinary Shares
|
Class B
Ordinary Shares
|
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total
Permanent
Equity (Deficit)
|
|||||||||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||||||||||
Balance — February 25, 2021 (inception)
|
|
—
|
|
$
|
—
|
|
|
—
|
|
$
|
—
|
|
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|||||||||
Issuance of Class B ordinary shares to Sponsor
|
— | — | — | — | 6,325,000 | 633 | 24,367 | — | 25,000 | |||||||||||||||||||||||||||
Net loss
|
— | — | — | — | — | — | — | (5,182 | ) | (5,182 | ) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance – March 31, 2021
|
|
—
|
|
$
|
—
|
|
|
—
|
|
$
|
—
|
|
|
6,325,000
|
|
|
633
|
|
$
|
24,367
|
|
$
|
(5,182
|
)
|
$
|
19,818
|
|
|||||||||
Net loss
|
— | — | — | — | — | — | — | (143 | ) | (143 | ) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance – June 30, 2021
|
|
—
|
|
$
|
—
|
|
|
—
|
|
$
|
—
|
|
|
6,325,000
|
|
|
633
|
|
$
|
24,367
|
|
$
|
(5,325
|
)
|
$
|
19,675
|
|
|||||||||
Sale of 25,000,000 Public Shares, net of underwriting discounts and offering expenses
|
25,000,000 | 237,519,733 | — | — | — | — | — | — | — | |||||||||||||||||||||||||||
Accretion of Class A ordinary shares to redemption value
|
— | 12,483,309 | — | — | — | — | (6,424,311 | ) | (6,058,998 | ) | (12,483,309 | ) | ||||||||||||||||||||||||
Sale of 640,000 Private Placement Shares
|
— | — | 640,000 | 64 | — | — | 6,399,936 | — | 6,400,000 | |||||||||||||||||||||||||||
Forfeiture of Founder Shares
|
— | — | — | — | (75,000 | ) | (8 | ) | 8 | — | — | |||||||||||||||||||||||||
Net loss
|
— | — | — | — | — | — | — | (250,898 | ) | (250,898 | ) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance – September 30, 2021
|
|
25,000,000
|
|
$
|
250,003,042
|
|
|
640,000
|
|
$
|
64
|
|
|
6,250,000
|
|
$
|
625
|
|
$
|
—
|
|
$
|
(6,315,221
|
)
|
$
|
(6,314,532
|
)
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities:
|
||||
Net loss
|
$ | (256,223 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||
Formation costs paid by Sponsor in exchange for issuance of Founder Shares
|
5,000 | |||
Interest earned on marketable securities held in Trust Account
|
(3,042 | ) | ||
Changes in operating assets and liabilities:
|
||||
Prepaid expenses
|
(897,311 | ) | ||
Accrued expenses
|
16,316 | |||
|
|
|||
Net cash used in operating activities
|
|
(1,135,260
|
)
|
|
Cash Flows from Investing Activities:
|
||||
Investment of cash into Trust Account
|
(250,000,000 | ) | ||
|
|
|||
Net cash used in investing activities
|
|
(250,000,000
|
)
|
|
Cash Flows from Financing Activities
|
||||
Proceeds from sale of Public Shares, net of underwriting discounts paid
|
245,600,000 | |||
Proceeds from sale of Private Placement Shares
|
6,400,000 | |||
Advance from related party
|
63,787 | |||
Repayment of advances from related party
|
(25,681 | ) | ||
Proceeds from promissory note – related party
|
300,000 | |||
Repayment of promissory note - related party
|
(300,000 | ) | ||
Payment of offering costs
|
(360,267 | ) | ||
|
|
|||
Net cash provided by financing activities
|
|
251,677,839
|
|
|
Net Change in Cash
|
|
542,579
|
|
|
Cash – Beginning of period (inception)
|
— | |||
|
|
|||
Cash – End of period
|
$
|
542,579
|
|
|
|
|
|||
Non-Cash
investing and financing activities:
|
||||
Offering costs paid by Sponsor in exchange for issuance of Founder Shares
|
$ | 20,000 | ||
|
|
|||
Deferred underwriting fee payable
|
$ | 7,700,000 | ||
|
|
Balance Sheet as of July 2, 2021
|
As Previously
Reported |
Adjustment
|
As
Restated
|
|||||||||
Class A ordinary shares subject to possible
redemption
|
$ | 238,939,400 | $ | 11,060,600 | $ | 250,000,000 | ||||||
Class A ordinary shares
|
$ | 175 | $ | (111 | ) | $ | 64 | |||||
Additional
paid-in
capital
|
$ | 5,004,525 | $ | (5,004,525 | ) | $ | — | |||||
Accumulated deficit
|
$ | (5,325 | ) | $ | (6,055,964 | ) | $ | (6,061,289 | ) | |||
Total Permanent Equity (Deficit)
|
$ | 5,000,008 | $ | (11,060,600 | ) | $ | (6,060,592 | ) | ||||
Number of
Class
A ordinary
shares
subject
|
23,893,940 | 1,106,060 | 25,000,000 |
Three Months Ended
September 30, 2021 |
For the Period from
February 25, 2021 (Inception)
Through
September 30, 2021
|
|||||||||||||||
Class A
|
Class B
|
Class A
|
Class B
|
|||||||||||||
Basic and diluted net loss per ordinary share
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Allocation of net loss
|
$ | (201,340 | ) | $ | (49,558 | ) | $ | (166,971 | ) | $ | (89,252 | ) | ||||
Denominator:
|
||||||||||||||||
Basic and diluted weighted average shares outstanding
|
25,358,242 | 6,241,758 | 10,884,906 | 5,818,396 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per ordinary share
|
$ | (0.01 | ) | $ | (0.01 | ) | $ | (0.02 | ) | $ | (0.02 | ) |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Description
|
Level
|
September 30,
2021 |
||||||
Assets:
|
||||||||
Marketable securities held in Trust Account
|
1 | $ | 250,003,042 |
No.
|
Description of Exhibit
|
|
3.1(1) | Amended and Restated Memorandum and Articles of Association of the Registrant. | |
10.1(2) | Letter Agreement, dated September 24, 2021, between the Company and Professor Solomon. | |
10.2(3) | Indemnity Agreement, dated September 24, 2021, between the Company and Professor Solomon. | |
10.3(4) | Director Restricted Stock Unit Award Agreement, dated September 24, 2021, between the Company and Professor Solomon. | |
31.1* | ||
31.2* | ||
32.1* | ||
32.2* | ||
101.INS* | XBRL Instance Document | |
101.SCH* | XBRL Taxonomy Extension Schema Document | |
101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | XBRL Taxonomy Extension Labels Linkbase Document | |
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document | |
104* | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
* |
Filed herewith.
|
(1) |
Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on July 2, 2021.
|
(2) |
Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on September 24, 2021.
|
(3) |
Incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on September 24, 2021.
|
(4) |
Incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed on September 24, 2021.
|
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. IV
|
||||||
Date: November 15, 2021 | By: |
/s/ Chamath Palihapitiya
|
||||
Name: | Chamath Palihapitiya | |||||
Title: | Chief Executive Officer | |||||
(Principal Executive Officer) | ||||||
Date: November 15, 2021 | By: |
/s/ James Ryans
|
||||
Name: | James Ryans | |||||
Title: | Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |
1 Year Social Capital Suvretta ... Chart |
1 Month Social Capital Suvretta ... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions